Description
+ Include: 29 videos + 1 pdf, size: 7.75 GB
+ Target Audience: transplant and cell therapy physicians
+ Sample video: contact me for sample video
+ Information:
The Australia and New Zealand Transplant and Cellular Therapies Limited (ANZTCT) Annual Scientific Meeting 2023 took place from 7th to 9th September 2023 at the Manly Pacific Hotel in Sydney, New South Wales, Australia. This inaugural event was organized by the ANZTCT, a non-profit society comprising healthcare professionals involved in bone marrow transplant and cellular therapies.
The meeting featured a comprehensive program that included clinical practice sessions, scientific presentations, research workshops, and educational training. It aimed to support participants in meeting their accreditation requirements and fostered engagement between patients, caregivers, and healthcare professionals. The event was held in partnership with the Australian Bone Marrow Donor Registry (ABMDR) and Arrow, the Bone Marrow Transplant Foundation to promote patient education and involvement.
Target Audience:
- Transplant and cell therapy physicians
- Trainees
- Nurses
- Care coordinators
- Quality managers
- Scientists
- Data managers
- Pharmacists
- Dietitians
- Physiotherapists
- Occupational therapists
- Psychologists
Key Features:
- Comprehensive program covering clinical practice, scientific presentations, research workshops, and education and training for all those involved in transplant and cellular therapy service delivery
- Networking opportunities with professionals across the Australia-Pacific region.
- Sessions designed to help participants meet their FACT/JACIE accreditation education requirements
+ Topics:
anztct-asm-2023-program-for-web.pdf
CART debate – Is autograft in Lymphoma and Myeloma Dead 1.mp4
CART debate – Is autograft in Lymphoma and Myeloma Dead 2.mp4
Donor sourcing – how that really works.mp4
Future of Microbiome in TCT.mp4
Graft versus Host Disease.mp4
How far can we mismatch to improve access to donors.mp4
Neurotx management.mp4
Oral Abstracts – Autologous stem cell mobilisation and transplant following bortezomib, lenalidomide and dexamethasone.mp4
Oral Abstracts – Developing a psycho-educational resource for family stem cell donors.mp4
Oral Abstracts – Optimising antifungal prophylaxis in allogeneic stem cell transplantation.mp4
Oral Abstracts – Optimising Bone Marrow Harvests- NMDP Mentorship & USA Centre of Excellence.mp4
Oral Abstracts – Post Allograft Immunoglobulin Replacement Study (PAIRS)- protocol for an observational cohort study.mp4
Oral Abstracts – Third-party partially HLA matched fungus-specific T-cells can lead to clearance of invasive fungal infections.mp4
Panel- The future of TCT in ANZ- Policy design and strategic planning.mp4
Plenary BMT Abstracts – Incidence, characteristics and organ involvement of chronic graft-versus-host disease.mp4
Plenary BMT Abstracts HLA-DPB1 protein expression in haematopoietic cell transplant patients in New Zealand.mp4
Plenary BMT Abstracts Secondary malignancy after allogeneic haematopoietic stem cell transplant in adults- a single-centre registry analysis.mp4
Plenary CT Abstracts National CART Adult outcome Data.mp4
Plenary CT Abstracts National Paediatric outcome Data.mp4
Plenary CT Abstracts Phenotyping CAR T-cells early post infusion reveals better clinical response rates for patients.mp4
Plenary CT Abstracts Real-world outcomes of brexucabtagene autoleucel (brexu-cel) for relapsed or refractory.mp4
PTCY in adults and paeds Why and how of PTCY.mp4
The importance and value of registry- CIBMTR perspectives.mp4
Update from the Te Tahu Hauora Health Quality & Safety Commission- Indigenous data Sovereignty.mp4
Update on the Australian Commission on Safety and Quality in Health Care Clinical Quality Registry Program.mp4
Vaccinations.mp4
Value of (FACT JACIE )Accreditation and improving patient outcomes.mp4
What it takes to support TCT patients- Patient and family Perspectives 1.mp4
What it takes to support TCT patients- Patient and family Perspectives 2.mp4
Reviews
There are no reviews yet.